default author photo

Vanessa Contreras

Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT)

55 Avenue de Paris

Versailles, 78000

France

SCHOLARLY PAPERS

2

DOWNLOADS

122

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Non-adjuvanted CD40-targeting SARS-CoV-2 Vaccines Induce Broad Long-lasting Protection in Non-human Primates

Number of pages: 48 Posted: 19 Sep 2025
University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris Est Créteil, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Bordeaux - ISPED, INSERM U1219, Inria BSO, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris Est Créteil, University of Lausanne - Service of Immunology and Allergy, University of Nantes - INSERM, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Lausanne - Service of Immunology and Allergy, University of Bordeaux - SISTM team, UMR 1219, University of Bordeaux - SISTM team, UMR 1219, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Claude Bernard Lyon 1 - Inserm
Downloads 71 (867,774)

Abstract:

Loading...

Preclinical study, Immunogenicity, SARS-CoV-2 vaccine candidate, Non-Human Primate, dendritic cell targeting vaccine, CD40

2.

Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection

Number of pages: 42 Posted: 24 Nov 2020
University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Life and Soft, Institut Cochin, University of Southampton - School of Biological Sciences, University of Southampton - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Department of Viroscience, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Washington - Department of Biochemistry, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), AIMM Therapeutics BV, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Erasmus Medical Center - Viroscience Department, University of Amsterdam - Amsterdam Public Health Research Institute, Life and Soft, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, University of Washington - Department of Biochemistry, University of Paris-Saclay - Molecular Genetics of RNA Viruses, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Amsterdam - Department of Medical Microbiology
Downloads 51 (1,052,702)

Abstract:

Loading...

SARS-CoV-2 vaccine, Self-assembling protein nanoparticle vaccine, SARS-CoV-2 NHP challenge study